A blocking peptide containing 15 amino amino terminus of human BCL-10.
Points forts
Source
Synthetic
(Accession #: AF134395) The Bcl-10 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-054865 |
|---|
| Réf. fabricant | 18705643 |
|---|
| Gene ID (Entrez) | 8915 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-76882. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | B-cell CLL/lymphoma 10 CIPERCLAPB-cell lymphoma/leukemia 10, Bcl-10, CARD-containing apoptotic signaling protein, CARD-containing molecule enhancing NF-kappa-B, CARD-containing proapoptotic protein, CARD-like apoptotic protein, CARMEN, caspase-recruiting domain-containing protein, cCARMEN, c-E10bcl-10, CED-3/ICH-1 prodomain homologous E10-like regulator, Cellular homolog of vCARMEN, cellular-E10, hCLAP, Mammalian CARD-containing adapter molecule E10, mE10CARD containing molecule enhancing NF-kB |
|---|
| Symbole de gène(s) | BCL10 |
|---|
| Type de produit | Bcl-10 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 15 amino amino terminus of human BCL-10 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
